Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2011; 17(4): 493-498
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.493
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.493
Table 1 Characteristics of 153 patients with a sustained virological response after peginterferon plus ribavirin combination treatment
| n (%) | |
| Age (mean ± SD, yr) | 47 ± 9 |
| Sex | |
| Female | 71 (46.4) |
| Male | 82 (53.6) |
| Genotypes | |
| 1 | 116 (75.8) |
| 2 | 1 (0.6) |
| 3 | 32 (21) |
| 4 | 4 (2.6) |
| Stage of fibrosis (before therapy) | |
| F1-2 | 140 (91.6) |
| F3 | 8 (5.2) |
| F4 | 5 (3.2) |
| Fibrosis by FibroScan® (mean ± SD, kPa) | 7 ± 4.3 |
| Type of PEG-IFN | |
| α-2a | 60 (39) |
| α-2b | 93 (61) |
| Follow-up [range (mean ± SD), mo] | 54-90 (76 ± 13) |
| Patients follow-up | |
| 5 yr | 130 (85) |
| 4 yr | 23 (15) |
- Citation: Trapero-Marugán M, Mendoza J, Chaparro M, González-Moreno L, Moreno-Monteagudo JA, Borque MJ, Moreno-Otero R. Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin. World J Gastroenterol 2011; 17(4): 493-498
- URL: https://www.wjgnet.com/1007-9327/full/v17/i4/493.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i4.493